Function of nonstructural 5A protein of genotype 2a in replication and infection of HCV with gene substitution

被引:1
|
作者
Wang, Yong-Zhi [2 ]
Wang, Wen-Bo [1 ]
Cao, Ming-Mei [1 ]
Wang, Wen [1 ]
Zhao, Lan-Juan [1 ]
Xu, Gang [1 ]
Ren, Hao [1 ]
Qi, Zhong-Tian [1 ]
机构
[1] Second Mil Med Univ, Shanghai Key Lab Med Biodef, Dept Microbiol, Shanghai 200433, Peoples R China
[2] 254 Hosp PLA, Dept Cardiol, Tianjin 300142, Peoples R China
关键词
Hepatitis C virus; Nonstructural; 5A; Chimera; Cell culture-produced virus; Replication; Infection; HEPATITIS-C-VIRUS; EFFICIENT REPLICATION; RNA REPLICATION; HEPATOCELLULAR-CARCINOMA; MUTATIONS; CULTURE; ENHANCEMENT; RISK; NS5A;
D O I
10.3748/wjg.v17.i29.3398
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To explore the function of Nonstructural 5A (NS5A) protein of genotype 2a (JFH1) in the replication and infection of hepatitis C virus (HCV). METHODS: Intergenotypic chimera FL-J6JFH/J4NS5A was constructed by inserting NS5A gene from 1b stain HC-J4 by the overlapping polymerase chain reaction (PCR) method and the restriction enzyme reaction. In vitro RNA transcripts of chimera, prototype J6JFH and negative control J6JFH1 (GND) were prepared and transfected into Huh-7.5 cells with liposomes. Immunofluorescence assay (IFA), fluorescence quantitative PCR and infection assay were performed to determine the protein expression and gene replication in Huh-7.5 cells. RESULTS: The HCV RNA levels in FL-J6JFH/J4NS5A chimera RNA transfected cells were significantly lower than the wild type at any indicated time point (2.58 +/- 5.97 x 10(6) VS 4.27 +/- 1.72 x 10(4), P = 0.032). The maximal level of HCV RNA in chimera was 5.6 +/- 1.8 x 10(4) GE/mu g RNA at day 34 after transfection, while the wild type reached a peak level at day 13 which was 126 folds higher (70.65 +/- 14.11 x 10(5) VS 0.56 +/- 0.90 x 10(5), P = 0.028). HCV proteins could also be detected by IFA in chimera-transfected cells with an obviously low level. Infection assay showed that FL-363FH/J4NS5A chimera could produce infectious virus particles, ranging from 10 +/- 5 ffu/mL to 78.3 +/- 23.6 ffu/mL, while that of FL-J6JFH1 ranged from 5.8 +/- 1.5 x 10(2) ffu/mL to 2.5 +/- 1.4 x 10(4) ffu/mL. CONCLUSION: JFH1 NS5A might play an important role in the robust replication of J6JFH1. The establishment of FL-J6JFH/J4NS5A provided a useful platform for studying the function of other proteins of HCV. (C) 2011 Baishideng. All rights reserved.
引用
收藏
页码:3398 / 3406
页数:9
相关论文
共 50 条
  • [41] Efficacy and changes of the nonstructural 5A gene by prolonged interferon therapy for patients with hepatitis C virus genotype 1b and a high level of serum HCV-RNA
    Arase, Y
    Ikeda, K
    Chayama, K
    Murashima, N
    Tsubota, A
    Suzuki, Y
    Saitoh, S
    Kobayashi, H
    Kobayashi, M
    Kobayashi, M
    Kumada, H
    INTERNAL MEDICINE, 1999, 38 (06) : 461 - 466
  • [42] Domain 2 of nonstructural protein 5A (NS5A) of hepatitis C virus is natively unfolded
    Liang, Yu
    Ye, Hong
    Kang, Cong Bao
    Yoon, Ho Sup
    BIOCHEMISTRY, 2007, 46 (41) : 11550 - 11558
  • [43] Duplication of V3 domain in nonstructural 5A protein of hepatitis C virus genotype 1b
    Veillon, P
    Redureau, J
    Coueffic, B
    Subra, JF
    Causse, X
    Gaudy, C
    Payan, C
    Lunel-fabiani, F
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S239 - S239
  • [44] Number and position of mutations in the interferon (IFN) sensitivity-determining region of the gene for nonstructural protein 5A correlate with IFN efficacy in hepatitis C virus genotype 1b infection
    Watanabe, H
    Enomoto, N
    Nagayama, K
    Izumi, N
    Marumo, F
    Sato, C
    Watanabe, M
    JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (08): : 1195 - 1203
  • [45] Efficacy of ledipasvir/sofosbuvir with or without ribavirin for 12 weeks in genotype 1b HCV patients previously treated with a nonstructural protein 5A inhibitor-containing regimen
    Ikeda, Hiroki
    Watanabe, Tsunamasa
    Shimizu, Hirohito
    Hiraishi, Tetsuya
    Kaneko, Rena
    Baba, Toshiyuki
    Takahashi, Hideaki
    Matsunaga, Kotaro
    Matsumoto, Nobuyuki
    Yasuda, Hiroshi
    Okuse, Chiaki
    Iwabuchi, Shogo
    Suzuki, Michihiro
    Itoh, Fumio
    HEPATOLOGY RESEARCH, 2018, 48 (10) : 802 - 809
  • [46] Mutations in the nonstructural protein 5A gene and response to interferon therapy in young patients with chronic hepatitis C virus 1b infection
    Komatsu, H
    Fujisawa, T
    Inui, A
    Miyagawa, Y
    Onoue, M
    JOURNAL OF MEDICAL VIROLOGY, 1997, 53 (04) : 361 - 365
  • [47] Nonstructural Protein 5A (NS5A) and Human Replication Protein A Increase the Processivity of Hepatitis C Virus NS5B Polymerase Activity In Vitro
    Mani, Nagraj
    Yuzhakov, Alexander
    Yuzhakov, Olga
    Coll, Joyce T.
    Black, Jim
    Saxena, Kumkum
    Fulghum, John R.
    Lippke, Judith A.
    Rao, B. Govinda
    Rijnbrand, Rene
    Kwong, Ann D.
    JOURNAL OF VIROLOGY, 2015, 89 (01) : 165 - 180
  • [48] PACSIN2 Interacts with Nonstructural Protein 5A and Regulates Hepatitis C Virus Assembly
    Nguyen, Lap P.
    Tran, Si C.
    Suetsugu, Shiro
    Lim, Yun-Sook
    Hwang, Soon B.
    JOURNAL OF VIROLOGY, 2020, 94 (05)
  • [49] HEPATITIS C VIRUS (HCV) REPLICATION CAPACITY CORRELATES WITH HCV NON-STRUCTURAL PROTEIN 5A (NS5A) TRANSCRIPTIONAL ACTIVATION IN VITRO
    Maqbool, Muhammad A.
    Lerat, Herve
    Pawlotsky, Jean-Michel
    HEPATOLOGY, 2010, 52 (04) : 818A - 818A
  • [50] Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders
    Chayama, Kazuaki
    Takahashi, Shoichi
    Toyota, Joji
    Karino, Yoshiyasu
    Ikeda, Kenji
    Ishikawa, Hiroki
    Watanabe, Hideaki
    McPhee, Fiona
    Hughes, Eric
    Kumada, Hiromitsu
    HEPATOLOGY, 2012, 55 (03) : 742 - 748